Me (ME) forms special board committee to explore strategic alternatives, including sale, restructuring, or business ...
Petros Pharmaceuticals , Inc. (NASDAQ:PTPI), a micro-cap pharmaceutical company with a market capitalization of $3.25 million, has reached an agreement with key investors to amend certain terms ...
Me still merchandises its ancestry, health analysis, and the Total Health annual package on a scale from $99 to $999 annually. Lemonaid entered the hot GLP-1 prescribing and support business in 2024, ...
Genetic testing firm 23andMe is reportedly considering the sale of its telehealth division, Lemonaid Health, according to ...
Me (ME) has been quietly exploring a possible sale of its telehealth business, Lemonaid, according to Business Insider.Stay Ahead of the ...
The struggling genetic-testing 23andMe is looking for a buyer for the virtual-care business it acquired in 2021, Business ...